1. Home
  2. ORMP vs ASRT Comparison

ORMP vs ASRT Comparison

Compare ORMP & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • ASRT
  • Stock Information
  • Founded
  • ORMP 2002
  • ASRT 1995
  • Country
  • ORMP United States
  • ASRT United States
  • Employees
  • ORMP N/A
  • ASRT N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORMP Health Care
  • ASRT Health Care
  • Exchange
  • ORMP Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • ORMP N/A
  • ASRT 57.9M
  • IPO Year
  • ORMP N/A
  • ASRT 1997
  • Fundamental
  • Price
  • ORMP $2.15
  • ASRT $0.69
  • Analyst Decision
  • ORMP Hold
  • ASRT Strong Buy
  • Analyst Count
  • ORMP 1
  • ASRT 2
  • Target Price
  • ORMP N/A
  • ASRT $3.25
  • AVG Volume (30 Days)
  • ORMP 63.0K
  • ASRT 259.0K
  • Earning Date
  • ORMP 08-15-2025
  • ASRT 08-06-2025
  • Dividend Yield
  • ORMP N/A
  • ASRT N/A
  • EPS Growth
  • ORMP N/A
  • ASRT N/A
  • EPS
  • ORMP N/A
  • ASRT N/A
  • Revenue
  • ORMP $2,000,000.00
  • ASRT $119,001,000.00
  • Revenue This Year
  • ORMP N/A
  • ASRT N/A
  • Revenue Next Year
  • ORMP N/A
  • ASRT $11.91
  • P/E Ratio
  • ORMP N/A
  • ASRT N/A
  • Revenue Growth
  • ORMP 196.74
  • ASRT N/A
  • 52 Week Low
  • ORMP $1.82
  • ASRT $0.51
  • 52 Week High
  • ORMP $3.09
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 46.79
  • ASRT 64.38
  • Support Level
  • ORMP $2.09
  • ASRT $0.63
  • Resistance Level
  • ORMP $2.20
  • ASRT $0.67
  • Average True Range (ATR)
  • ORMP 0.09
  • ASRT 0.03
  • MACD
  • ORMP -0.00
  • ASRT 0.01
  • Stochastic Oscillator
  • ORMP 36.84
  • ASRT 86.37

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: